[144] Camtek Ltd SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Camtek Ltd (CAMT) shows a proposed sale of 8,504 ordinary shares through Oppenheimer & Co. Inc. on or about 08/14/2025 with an aggregate market value of $749,457.52. The filing lists the acquisition details for those shares: a mix of performance share units (PSUs) and restricted stock units granted by the issuer between 04/28/2021 and 01/16/2023, totaling the reported units by grant date and type. The filing states there were no securities sold by the reporting person in the past three months. The filer affirms no undisclosed material adverse information and includes the standard signature statement regarding accuracy.

Insights

Securities Analyst

TL;DR: A holder filed to sell 8,504 ordinary shares via broker, reporting grants from 2021–2023; the notice is a routine insider disposition filing.

The Form 144 indicates a proposed sale executed through Oppenheimer & Co. Inc., with the securities traced to PSU and RSU grants from the issuer dated 04/28/2021, 01/24/2022 and 01/16/2023. The filing discloses the aggregate market value of the proposed sale ($749,457.52) and the issuer's total shares outstanding (45,449,306). The filer also reports no sales in the prior three months and includes the required attestation about material information. From a compliance and disclosure standpoint, this meets the Rule 144 notice requirements for an insider seeking to sell restricted or control securities.

Corporate Governance Expert

TL;DR: This is a standard Rule 144 notice documenting insider-held equity from issuer grants and a planned brokered sale.

The document details the provenance of the securities (PSUs and RSUs issued by the company) and provides per-lot acquisition dates and quantities. It includes the broker name and the approximate sale date, and the filer’s representation that no material undisclosed information exists. As presented, the filing is procedural, fulfilling disclosure obligations tied to sales of issuer-originated equity by an insider or affiliate.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	8504	749457.52	45449306	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/16/2023	PSU	From the Issuer			1854	01/16/2023	N/A
Ordinary	01/24/2022	PSU	From the Issuer			618	01/24/2022	N/A
Ordinary	04/28/2021	PSU	From the Issuer			472	04/28/2021	N/A
Ordinary	01/16/2023	Restricted Stock Units	From the Issuer			3478	01/16/2023	N/A
Ordinary	01/24/2022	Restricted Stock Units	From the Issuer			1373	01/24/2022	N/A
Ordinary	04/28/2021	Restricted Stock Units	From the Issuer			709	04/28/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CAMT report?

The filing reports a proposed sale of 8,504 ordinary shares through Oppenheimer & Co. Inc. with an aggregate market value of $749,457.52 and an approximate sale date of 08/14/2025.

What types of securities are being sold in the CAMT Form 144?

The securities are ordinary shares that were acquired as performance share units (PSUs) and restricted stock units (RSUs) granted by the issuer between 04/28/2021 and 01/16/2023.

Who is the broker named in the CAMT Form 144?

The broker named for the proposed sale is Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004.

Did the filer report any sales in the past three months?

The filing states Nothing to Report for securities sold by the person in the past three months.

How many shares outstanding does the filing list for the issuer?

The filing lists 45,449,306 shares outstanding.